NAS10029,430−1.28%S&P7,718−0.34%GOLD$4,038−0.34%BTC$80,235−1.27%VIX16.92+0.06%latest tape · as of 14:02 UTC
The Screen · Communication Services · Internet Content & Information
Genius Sports Limited
GENI · the NYSE · USD · Market cap $1.8B · 2,000 employees
Genius Sports Limited provides technology-led products and services to the sports, sports betting, and sports media industries in the Americas, Europe, and internationally.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.09, read 2026-10-22
Ethical passes the values gate
Price6.35 USD
Fair value12.70
Ethical score70.0/100
Our investment reviews on this name
2026-10-11Read Markup6.22+2.1% to today ✓Distribution gives way to Markup after an 8% rise in 9 days
2026-10-02Read Distribution5.76+10.2% to today Markup gives way to Distribution after a 16% slide in 13 weeks
2026-07-02Read Markup6.85-7.3% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Genius Sports Limited holds its Accumulation at $6.35. The statistical read favours the sellers, held for 90 days.
As held on the ledger · 2026-10-28
Phase
Accumulation
Quantitative state
The statistical read favours the sellers, held for 90 days
Price at the screen
$6.35
Valuation
N/A trailing · 6.11 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.91
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
2.70%
Below 33%
Interest-bearing debt is just 2.7% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
36.35%
Below 49%
Money owed to the company is 36.4% of assets, under the 49% limit.
Pass
Revenue purity
0.18%
Below 5%
Only 0.2% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Genius Sports clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 3%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when GENI's ethical verdict changes
Today GENI passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-28 screen. The gold marker is the market price at the same screen. A 100.0% margin of safety to the base estimate.
Third-party analyst targets: 21 covering, consensus Strong Buy. The average target sits +65% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-28 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Sports betting data still needs a profitable collector
Every time a goal is scored or an odds line moves, the raw data has to be captured, cleaned and sold in milliseconds. Genius Sports sits in that pipe, supplying the infrastructure that bookmakers and broadcasters rely on across Europe and the Americas. Revenue is expanding at 30 percent, the forward multiple sits at just 6.5 times and the ethical screen is clear.
Yet the numbers still do not add up. Profit margins remain negative at minus 22 percent and return on equity is minus 23 percent, so the low multiple reflects losses rather than a bargain. With an opportunity rating of none we stay on the side-lines even though analysts see upside to ten dollars and our own fair value sits higher.
Currency swings, customer concentration and the race to stay ahead of bigger data rivals keep execution risk elevated. Until cash generation turns consistently positive the valuation gap is more trap than opportunity.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day; its business and earnings are exposed to United Kingdom and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
GENI trades on the NYSE (the company is based in United Kingdom). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-25Markup$6.54-0.6%Entry 9
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (18 analysts) rates it strong buy, with a mean price target of $10. Insiders have been net sellers over the past quarter.
2026-10-18Markup$6.58+5.8%Entry 8
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 5.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (18 analysts) rates it strong buy, with a mean price target of $10. Insiders have been net sellers over the past quarter.
2026-10-11Markup · changed$6.22+8.0%Entry 7
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 8.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (18 analysts) rates it strong buy, with a mean price target of $10. Insiders have been net sellers over the past quarter.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 27.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (18 analysts) rates it strong buy, with a mean price target of $10. Insiders have been net sellers over the past quarter.
2026-08-30Markup$7.96+26.3%Entry 5
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 26.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (18 analysts) rates it strong buy, with a mean price target of $10.
2026-07-31Markup$6.30-8.0%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 8.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (18 analysts) rates it strong buy, with a mean price target of $10.
2026-07-18Markup$6.85+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (18 analysts) rates it strong buy, with a mean price target of $10.
2026-07-03Markup$6.85+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
2026-07-02Markup$6.85Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
